Breast Comprehensive Panel NGS Genetic Test Price 4400 AED
Navigating Your Health: An Insight into the Breast Comprehensive Panel NGS Genetic Test in the UAE
Breast cancer is a significant health issue for many women in the UAE. The Breast Comprehensive Panel Next-Generation Sequencing (NGS) Genetic Test serves as an essential resource for those who wish to proactively assess their personal risk of developing breast cancer.
Decoding the NGS Test: Unveiling Your Genetic Profile
Our genes are the architects of our physical attributes and health. NGS technology enables scientists to examine a large segment of your genes at once. The Breast Comprehensive Panel NGS Genetic Test is designed to target genes linked with a heightened risk of developing breast cancer.
Why Opt for the Breast Comprehensive Panel NGS Genetic Test?
Knowledge Empowers: This test equips you with crucial information about your genetic susceptibility to breast cancer, enabling you to make educated health decisions in consultation with your doctor. Early Detection Leads to Improved Prognosis: Recognizing a genetic risk factor for breast cancer facilitates earlier detection through regular screenings and potential risk-mitigation strategies, significantly enhancing treatment outcomes and overall prognosis. Considerations for Family Planning: If breast cancer runs in your family, this test can ascertain if you possess genes that could be inherited by your children. This information is invaluable for genetic counseling and family planning discussions.
Advantages of the Breast Comprehensive Panel NGS Genetic Test in the UAE:
Cutting-Edge Technology: NGS provides a more thorough analysis than conventional genetic testing methods, potentially uncovering a wider array of potential risk factors. Proactive Stance: This test enables you to adopt a proactive stance towards your breast health, facilitating early intervention and preventive actions. Peace of Mind: Understanding your genetic composition can offer peace of mind or stimulate further conversations with your doctor to devise a personalized healthcare strategy.
Who Stands to Gain from the Breast Comprehensive Panel NGS Genetic Test? T
his test is particularly beneficial for women who have: A family history of breast cancer, particularly in immediate relatives (mother, sister, daughter) A personal history of specific benign breast conditions Worries about their inherited risk of breast cancer
What Does the Test Involve?
The Breast Comprehensive Panel NGS Genetic Test typically requires a straightforward blood draw. There’s generally no special preparation needed.
Interpreting the Results and Future Course of Action:
A genetic counselor will decode your test results and elucidate their implications for your breast cancer risk. The results may suggest:
Negative Result: This signifies no detected genetic mutations linked with a high risk of breast cancer. However, routine screenings are still advised. Positive Result: A positive result doesn’t assure you will develop breast cancer, but it does suggest a higher risk. Your doctor will discuss personalized risk-reduction strategies such as increased screening frequency, preventive medications, or potential lifestyle changes.
The Importance of Genetic Counseling:
It’s highly recommended to consult a genetic counselor before and after the test. The counselor can elaborate on the test, address any concerns you might have, and guide you through the implications of the results for your unique situation.
Taking the Reins of Your Breast Health
If you’re apprehensive about your risk of breast cancer, discussing the Breast Comprehensive Panel NGS Genetic Test with your doctor in the UAE can be a pivotal move towards a proactive approach to your health. Early detection and knowledge are potent weapons in the battle against breast cancer.
Test Cost:
AED 4400.0
Test Name
Breast Comprehensive Panel NGS Genetic DNA Test
Components
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Cancer
Doctor
Oncologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for Breast Comprehensive Panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2
Test Details
Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests.
The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D.
This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries.
It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics.
| Test Name | Breast comprehensive panel NGS Genetic DNA Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for Breast comprehensive panel NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABRAXAS1, ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, DICER1, EPCAM, FANCC, MEN1, MLH1, MRE11, MSH2, MSH6, MUTYH, NBN, PALB2, PMS1, PMS2, PTEN, RAD50, RAD51C, RAD51D, RECQL, SMARCA4, STK11, TP53, XRCC2 |
| Test Details | Breast comprehensive panel NGS genetic DNA test is a type of genetic test that analyzes specific genes associated with breast cancer. This panel test uses next-generation sequencing (NGS) technology to examine multiple genes simultaneously, providing a more comprehensive analysis than traditional single-gene tests. The breast comprehensive panel NGS genetic DNA test can identify mutations in genes such as BRCA1 and BRCA2, which are associated with an increased risk of developing breast and ovarian cancer. Other genes analyzed in this panel may include ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, RAD51C, and RAD51D. This test is typically recommended for individuals with a personal or family history of breast cancer, particularly if there are multiple cases of breast or ovarian cancer in the family, early onset of breast cancer, or male breast cancer. The results of this test can help inform medical management decisions, such as increased surveillance or risk-reducing surgeries. It is important to note that not all genetic mutations identified by this test are definitively associated with an increased risk of breast cancer, and the interpretation of test results should be done in consultation with a healthcare provider trained in genetics. |
